Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

29.36%

Threshold

Crossed downwards

Timeline

Published

21.02.2018

Transaction

14.02.2018

Voting rights breakdown

Voting rights acquired0.5%
Voting rights sold29.36%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAI2K00017

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, 4410 Liestal

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open